rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
22
|
pubmed:dateCreated |
1999-12-14
|
pubmed:abstractText |
Cyclooxygenase (COX)-inhibiting drugs have antitumor activity in canine and rodent models of urinary bladder cancer. Two isoenzymes of COX have been identified, COX-1 and COX-2. The purpose of this study was to characterize COX-1 and COX-2 expression in human invasive transitional cell carcinoma of the urinary bladder by immunohistochemistry and Western blot analysis. COX-2 was not expressed in normal urinary bladder samples but was detected in 25 of 29 (86%) invasive transitional cell carcinomas of the urinary bladder and in 6 of 8 (75%) cases of carcinoma in situ. These results indicate that COX-2 may play a role in bladder cancer in humans and support further study of COX-2 inhibitors as potential antitumor agents in human bladder cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0008-5472
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5647-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10582676-Aged,
pubmed-meshheading:10582676-Blotting, Western,
pubmed-meshheading:10582676-Carcinoma, Transitional Cell,
pubmed-meshheading:10582676-Carcinoma in Situ,
pubmed-meshheading:10582676-Cyclooxygenase 1,
pubmed-meshheading:10582676-Cyclooxygenase 2,
pubmed-meshheading:10582676-Female,
pubmed-meshheading:10582676-Humans,
pubmed-meshheading:10582676-Immunohistochemistry,
pubmed-meshheading:10582676-Isoenzymes,
pubmed-meshheading:10582676-Male,
pubmed-meshheading:10582676-Membrane Proteins,
pubmed-meshheading:10582676-Middle Aged,
pubmed-meshheading:10582676-Neoplasm Proteins,
pubmed-meshheading:10582676-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:10582676-Urinary Bladder Neoplasms
|
pubmed:year |
1999
|
pubmed:articleTitle |
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder.
|
pubmed:affiliation |
Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, Indiana 47907, USA.
|
pubmed:publicationType |
Journal Article
|